FDA rejects Lykos MDMA assisted psychotherapy for PTSD, requesting additional Phase-3 trial…

Why we need a revolution in clinical research. New editorial Brain academic.oup.com/brain/article/… National Institute for Health and Care Research Medical Research Council UK Research and Innovation Wellcome Wes Streeting

Had so much fun talking about cerebellum, psychosis, circuits and magnets with ⁦StoodleyLab⁩, ⁦Hengyi Cao⁩ and ⁦markhalko⁩ at the ⁦@LMU_Uniklinikum⁩ #ECSR2024

Fantastic day at the #Synapsy Celebrales Day at the BFM in #Geneva with Synapsy Centre UNIGE. Lots of bright minds to explain how we make progress in mental health and #neuroscience, and lots of great interactions!

And the only female is holding the microphone 🤯

1/4 - Une récente méta-analyse portant sur plus de 600’000 participants montre que le sentiment de solitude est un facteur de risque de déclin cognitif lié à l’âge (HR=1,30) de même force que le tabac fumé. nature.com/articles/s4422…

We are thrilled to address the opportunities and challenges in #BrainHealth delivery and education. In this letter, we highlight the need for comprehensive interdisciplinary education for the next generation of specialists in #BrainMedicine. Link in comment👇

Faculty Position Open Université de Genève . Seeking Associate/Assistant Professor in Genetics & Language Development Focus: Genetic influences on human language Part of @NCCRevolving Geneva, Switzerland 🗓️ Start: Sept 2025 📅 Apply until November 25th, 2024 unige.ch/medecine/fr/or…

📅 On Nov. 12, join us in Brussels at Polska Akademia Nauk "Brainstorming the Future of Brain Health". Our Coordinator will present the way towards the EU Partnership for Brain Health, followed by a panel discussion with Kasia Jurczak, Dr. Mazurek, Prof. Amunts & Prof. Dr. Indrit Bègue.

SSBP annual meeting is going excellent. The General Assembly has just appointed a new executive board. Young investigator awards went to Friederike Holze and Flurin Cathomas Poster award to Lijing Xin

I look forward to bringing the Swiss perspective in this European panel!

Mark Hallett's Wartenberg lecture on FND at the American Academy of Neurology. neurology.org/doi/10.1212/... and if you cant access the article... this NotebookLM 20 min podcast gives a good summary. notebooklm.google.com/notebook/1513f…

.EBRAINS Joint-CEO Prof. Katrin Amunts participated in a policy panel discussion at the “Brainstorming the Future of Brain Health” event on November 12, in Brussels. The event facilitated a dialogue with the upcoming European Partnership for Brain Health. Read more:

Nature Communications Cerebellar-driven cortical dynamics can enable task acquisition, switching and consolidation nature.com/articles/s4146…

Anatomy of Moncrieff's Anti-Medication Playbook Dr Joanna Moncrieff has a carefully honed 3-step strategy of attacking psychiatry, which she has used with remarkable power against the medical establishment. Step 1: Identify a narrow, technical assertion pertaining to the

Wrote Scientific Reports 02/2024 that their new meta-analysis on mindfulness & brain morphology excluded all null-findings and therefore by definition found a relation. Still no proper response from (other then many "we'll look into it"). It's been a year now.

I'm from Italy, the country that gave the world the Pope, and I can guarantee that, for the majority of us, this picture still looks as alien as a frame from a dystopian movie

This is misleading because the speaker is mixing apples and oranges. Different MH conditions follow different trajectories. Depression (and prescriptions) may increase with age as he says. But bipolar disorder and psychotic disorders (eg, schizophrenia) are most often recognized

Outcomes for the first 60 MDD patients treated at our clinic Queensland Neurostimulation Centre with robotically delivered & fMRI-personalized rTMS MADRS response=74%, remission=53% for RCT patients EXCITED to see fMRI moving from research to real-world clinical use! karger.com/pps/article/do…

The kind of emails that make your day.✨ This is the second big paper from my lab this year and resumes TMS targets across 4’283 patients living with Schizophrenia 🧲🧠 Great work led by Lorina Sinanaj & Kostas Pallis at Synapsy Center for Neuroscience and Mental Health Research.